Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
20 companies reporting in the next 90 days. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Tuesday, Nov 3 · in 68 days · 1 company | |||||
| CYRX | Cryoport, Inc. | Cell therapy | $846.85M | +10.36% | |
| Thursday, Nov 5 · in 70 days · 7 companies | |||||
| IOVA | Iovance Biotherapeutics, Inc. | Cell therapy | $3.82B | +72.24% | |
| BLFS | BioLife Solutions, Inc. | Cell therapy | $1.82B | +24.94% | |
| SANA | Sana Biotechnology, Inc. | Cell therapy | $1.23B | +25.00% | |
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| ALLO | Allogene Therapeutics, Inc. | Cell therapy | $749.72M | +24.00% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | Cell therapy | $501.00M | +1.91% |
| RNAC | Cartesian Therapeutics, Inc. | Cell therapy | $304.37M | +33.25% |
| LCTX | Lineage Cell Therapeutics, Inc. | Cell therapy | $275.67M | +9.71% |
| Friday, Nov 6 · in 71 days · 1 company | |||||
| LYEL | Lyell Immunopharma, Inc. | Cell therapy | $379.58M | +19.52% | |
| Monday, Nov 9 · in 74 days · 1 company | |||||
| PROK | ProKidney Corp. | Cell therapy | $690.59M | +12.34% | |
| Tuesday, Nov 10 · in 75 days · 2 companies | |||||
| CAPR | Capricor Therapeutics, Inc. | Cell therapy | $481.97M | +18.43% | |
| NKTX | Nkarta, Inc. | Cell therapy | $194.10M | +19.91% | |
| Wednesday, Nov 11 · in 76 days · 3 companies | |||||
| LEGN | Legend Biotech Corporation | Cell therapy | $4.14B | +10.53% | |
| KYTX | Kyverna Therapeutics, Inc. | Cell therapy | $546.70M | +11.62% | |
| MXCT | MaxCyte, Inc. | Cell therapy | $139.33M | +32.35% | |
| Thursday, Nov 12 · in 77 days · 4 companies | |||||
| VOR | Vor Biopharma Inc. | Cell therapy | $1.30B | +23.51% | |
| IPSC | Century Therapeutics, Inc. | Cell therapy | $392.93M | +3.83% | |
| FATE | Fate Therapeutics, Inc. Common Stock | Cell therapy | $305.54M | +4.94% | |
| 0HIY.L | Atara Biotherapeutics, Inc. | Cell therapy | $124.82M | +1.60% | |
| Monday, Nov 16 · in 81 days · 1 company | |||||
| CABA | Cabaletta Bio, Inc. | Cell therapy | $545.94M | +18.38% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.